A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT01248923 · COMPLETED
Trial details
- NCT number
- NCT01248923
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.